These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 25807103

  • 1. Severe dilated cardiomyopathy induced by adalimumab and ustekinumab.
    Membrillo de Novales FJ, Ávila Jiménez A, Merino Meléndez L, Torres León J, López Soberón E, Fe Marqués A, Pérez Mochales JF.
    J Clin Rheumatol; 2015 Apr; 21(3):171-3. PubMed ID: 25807103
    [No Abstract] [Full Text] [Related]

  • 2. Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice.
    Del Alcázar Viladomiu E, Lamas Doménech N, Salleras Redonnet M.
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):606-610. PubMed ID: 30803689
    [No Abstract] [Full Text] [Related]

  • 3. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis.
    Phan C, Beauchet A, Burztejn AC, Severino-Freire M, Barbarot S, Girard C, Lasek A, Reguiai Z, Hadj-Rabia S, Abasq C, Brenaut E, Droitcourt C, Perrussel M, Mallet S, Phan A, Lacour JP, Khemis A, Bourrat E, Chaby G, Deborde R, Plantin P, Maruani A, Piram M, Maccari F, Fougerousse AC, Kupfer-Bessaguet I, Balguérie X, Barthelemy H, Martin L, Quiles-Tsimaratos N, Mery-Brossard L, Pallure V, Lons-Danic D, Bouilly-Auvray D, Beylot-Barry M, Puzenat E, Aubin F, Mahé E, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie.
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1984-1992. PubMed ID: 30883928
    [Abstract] [Full Text] [Related]

  • 4. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris.
    Takahashi T, Asano Y, Shibata S, Nakamura K, Nakao M, Shida R, Mitsui A, Araki M, Watanabe R, Fujita H, Tada Y, Sato S.
    Br J Dermatol; 2015 Oct; 172(5):1458-60. PubMed ID: 25565011
    [No Abstract] [Full Text] [Related]

  • 5. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A, Ivić I, Marasović-Krstulović D, Puizina-Ivić N.
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract] [Full Text] [Related]

  • 6. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
    Echeverría-García B, Nuño-González A, Dauden E, Vanaclocha F, Torrado R, Belinchón I, Pérez-Zafrilla B, Grupo de estudio BIOBADADERM.
    Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
    [No Abstract] [Full Text] [Related]

  • 7. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N, Yalcin B, Sallahoglu K, Rezvani A.
    Am J Ther; 2018 Mar; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.
    Haberman RH, Castillo R, Scher JU.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):e225-e226. PubMed ID: 33369644
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
    Megna M, Napolitano M, Balato N, Monfrecola G, Villani A, Ayala F, Balato A.
    Clin Exp Dermatol; 2016 Jul 01; 41(5):564-6. PubMed ID: 27028505
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis.
    Fioranelli M, Roccia MG, Lotti T.
    Dermatol Ther; 2017 Sep 01; 30(5):. PubMed ID: 28508536
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
    Benzaquen M, Monnier J, Beaussault Y, Rouby F, Berbis P.
    Australas J Dermatol; 2017 Nov 01; 58(4):e270-e271. PubMed ID: 28660635
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.